Mortality Due to COVID-19 in the COVID-AGEBRU Study

NCT04756479 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2022-04-06

No results posted yet for this study

Summary

The COVID-Age Brugmann study aims to identify the clinical predictors of mortality risk in older patients admitted to an acute care unit due to COVID-19

Conditions

  • Old Age; Debility
  • Covid19
  • Morbidity, Multiple

Sponsors & Collaborators

  • Brugmann University Hospital

    lead OTHER

Principal Investigators

  • Murielle MS Surquin, MD PhD · CHU Brugmann, Director of the Geriatrics Department

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04756479 on ClinicalTrials.gov